chrisvoncsefalvay/vaers-outcomes huggingface dataset:
bad  coughing; flu like symptoms; Sore Throat; has been in the  bed  since last  night; Chills; Headache; achy body; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (bad  coughing), INFLUENZA LIKE ILLNESS (flu like symptoms), OROPHARYNGEAL PAIN (Sore Throat), BEDRIDDEN (has been in the  bed  since last  night) and CHILLS (Chills) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Aug-2021 at 10:00 AM, the patient experienced COUGH (bad  coughing), INFLUENZA LIKE ILLNESS (flu like symptoms), OROPHARYNGEAL PAIN (Sore Throat), BEDRIDDEN (has been in the  bed  since last  night), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (achy body). At the time of the report, COUGH (bad  coughing), INFLUENZA LIKE ILLNESS (flu like symptoms), OROPHARYNGEAL PAIN (Sore Throat), BEDRIDDEN (has been in the  bed  since last  night), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (achy body) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information is not provided by the reporter.  Concomitant medication included Unspecified Blood pressure medication 10 mg.
Initial report received on 15 November 2012 from an investigator. A 24-year-old male subject, with no relevant past medical history received the following vaccines on 09 January 2012: smallpox (vaccinia) vaccine, (lot number, not reported) and concomitant anthrax vaccine (other manufacturer, lot number not reported); (route, site and dose number not reported); (route, site and dose number not reported for either vaccine). Seven days later on 16 January 2012, the subject developed possible myopericarditis of mild severity (also reported as six days post inoculation). The subject reported intermittent chest pressure, mild, with onset seven days post vaccination, occurring over three days (also reported as four days), which he noted when lying supine, but resolved when lying on right side. He also reported symptoms consistent with a mild upper respiratory illness, including cough, runny nose and sinus congestion which started on 14 January 2012 and resolved on 17 January 2012 without treatment. The subject also reported mild swollen glands under left underarm and chest pressure on 16 January 2012, which resolved on 19 January 2012 without treatment or medication. Vaccination site (unspecified vaccine) was left arm. On 25 January 2012, a rapid Troponin 1 level was reported as normal, less than (<) 0.10ng/mL. specimens for Immunogenicity Aliquot 2 and Immunogenicity Blood Clot were collected on 25 January 2012, with no results reported; and an electrocardiogram (ECG) was reported as abnormal with Intraventricular Conduction Defect and flat T waves. The subject took no concomitant medications and treatments were reported as none. The subject was given a Cardiology referral, which the patient did not wish to follow-up as he stated he felt the episode was due to high elevation with intense training and carrying a heavy backpack. On 08 February 2012, the patient was advised to follow-up with cardiology if symptoms reoccur. On 18 July 2012, the investigator documented on Medical Record that given report of Intraventricular Conduction Defect, she recommended contacting the subject to give him results and encourage him to see a cardiologist "although not related to vaccine." The subject's outcome was reported as resolved four days later on 19 January 2012. According to the investigator the event possible myopericarditis was possibly related to the trial product or the trial procedures. Documents held by sender: Medical Records.
Patients primary provider states that patient had an episode of bloody stools on 9-14-14, which is 2 days after the vaccination was administered.
Pt received initial dose of ADACEL 11/6/06. Pt then received 2nd dose 6/26/08.
Patient was receiving Catch Up doses on vaccine schedule.  Patient was given Kinrix vaccine for (DTaP/IPV).  Kinrix not licensed for <4yo.
Patient received FLUZONE vaccine in left deltoid on September 19, 2011. Mother called office 9-21-11 stating she noticed large rash (50 mm) at vaccination site. Patient advised to come in same day for evaluation and treatment.
Received tdap in the afternoon of 1-06-09. At 6pm that evening noticed a rash around site (Left arm) that injection was given. Reported this on 1-09-09 to agency. Was seen at that time by Dr.  Measured an area of erythema 5cm X 6cm. Was slightly reddened. Denied any pain, pruritus or drainage. Dr. informed  pt. to  take zyrtec. Will rtc if worsens. No red streaks noted per Dr.
Exactly 12 hours after shot I had pain, swelling, redness on arm and nausea. See picture 1. By morning the redness and swelling had grown. By night time it had spread all the way to my elbow. This lasted for four days before it began to subside. I am only concerned about what will happen if I get the 2nd shot in the series. Is this a normal reaction or should I not take the chance with the 2nd shot?
I started light spotting about a week after injection and when my period came on October 14th it was extremley heavy and cramps which i have never had an issue with up to this point and i usually am on the 1st of every month and this month i was 13 days late .  I will see how Nov 2021 is and if it is normal or its similar to October 2021.
Progressive heart condition that has lead to me having a heart attack, spinal degeneration, loss of circulation to limbs, loss of mobility that comes and goes. Loss of spinal volumez
This spontaneous report as received from an immunization coordinator refers to an unknown number of patients of unknown age and gender. No information regarding their pertinent medical history, concomitant medications, drug reactions, or allergies was provided. Since an unknown date in January 2017, the patient was receiving incorrectly stored doses of PROQUAD (Albumin status: recombinant human albumin (rHA); lot # M035145, expiration date: 30-JAN-2018; lot# M036295, expiration date: 13-FEB-2017; lot# M038862, expiration date: 13-MAR-2018; dose and route of administration were not provided). No adverse effects were reported. Administered doses of vaccine experienced the temperature excursion of above 46 degrees Fahrenheit (F) but below 77 F for an unspecified time. There was the following previous temperature excursions: above 14 F but below 46 F (above 10 degrees Celsius but below 8 degrees Celsius) for 23 hours, and above 46 F but below 77 F (above 8 degrees Celsius but below 25 degrees Celsius) for 12 hours. Digital Data Logger was involved. This is one of two reports received from the same reporter. Additional information is not expected, as there was no consent to contact the reporter. Sender's Comments: US-009507513-1703USA000248.
Pt was given vaccines today and discharged home. Mother reports Pt had seizure on way home and was instructed to go to this facilities ER was seen in ER on 7/30/18 and Dx with vasovagal syncope, syncope, was convulsive.
No adverse event till three days later my face became extremely swollen bright red and fire hot unforgivable itchy dry and urticaria which worsened and my eyes were swollen shut and the skin on my face in the dry areas peeled lasted five Days then slowly subsided also I developed urticaria on my entire chest neck and arm  right arm. I have bruising and blotchy redness but no throat tingling or tightness thank God. MISERABLE. I changed detergent and did everything praying it wasn?t the vaccine but ice constantly did not help at all. My eyes were weeping water fluid like dyshydrotic eczema
This spontaneous case was reported by a consumer and describes the occurrence of HOT FLUSH (covid vaccine cause you to have hot flashes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (covid vaccine cause you to have hot flashes). At the time of the report, HOT FLUSH (covid vaccine cause you to have hot flashes) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not reported.
After receiving my first dose of the Moderna Vaccination On 8/03/2021 I instantly felt a rapid heart flutter along with minor chest pain within the first hour of receiving the injection. The following day I experienced intermittent heart inflammation described as a ?Charlie horse? like pain in my heart after walking for less than 10 minutes, not being able to continue walking due to distressing pain. I have also awakened during the night due to feeling this pain as it comes and goes. I was then seen by my doctor on 09/02/2021 as my side effects had not improved. I wasn?t taken seriously and was told that I have a generalized anxiety disorder and that was why I had ?chest pain?. I implemented getting standard tests done such as a same day (09/02/2021) EKG and lab work including Hepatic function, Amylase, and CRP which appeared to look normal. My doctor then told me there have been heart inflammation cases reported and that my side effect would simply ?go away? within the next couple weeks and recommend to still get the second COVID-19 shot as my heart inflammation does not outweigh the ?benefit? of the vaccine. She also told me she would be reporting my heart inflammation to Moderna. I then received the second COVID-19 Dose on 09/18/2021 and began to feel extremely itchy skin the same day with redness. A few days later on 09/21/2021 I noticed a small unusual rash like patch on my right leg and decided to keep an eye on it because it was small. Within a week the red patch became scaly, larger, itchier with minor burning sensations, and had appeared onto my torso as well. Because of the rash?s appearance I used an over the counter natural oil remedy commonly used for ringworm for one month and noticed no improvement. I then saw my primary care physician on 11/04/2021 and was prescribed Fluconazole 150mg and also had a fungus culture taken which came back negative.  Ever since the in office visit, the urticarial skin rash had continued to grow, up to two inches in length, including multiple lesions on my torso, arms, legs, chest, and back. I had a follow up visit on 12/16/2021 still appearing to have the same side effect and asked my doctor for a dermatologist referral which I currently am in the process of being scheduled for, and also asked for a steroid cream which she then decline. As of 12/22/2021 I am experiencing both heart inflammation and a urticarial skin rash in response to the COVID-19 vaccination with no signs of improvement and am seeking proper care in the meantime. Please take what I have said into serious consideration and use it for educational purposes to review and research these effects. I?d like to thank you for taking the time to review my report.
On 7/5/02 T.C. from client stating that day following vaccine she experienced soreness in left arm, following day she had tingling in left leg which progressed to tingling and numbness in left big toe. 7/12/02 T.C. to client who reports she still has numbness in L toe but no increase in symptoms.
feel really lousy; Felt a little drained, i'm tired of therapy i've had enough.; I have no freaking energy; This is a spontaneous report from a contactable other healthcare professional (patient) from a Pfizer Sponsored Program. A 62-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 10May2021 (at the age of 62-year-old) as dose 2, single for COVID-19 immunisation; axitinib (INLYTA, Batch/Lot number was not reported; Expiration Date: 31Jul2023), tablet orally from 25Mar2020 and ongoing, at 5 mg, 2x/day for renal cancer. Medical history included dysphonia from an unknown date and unknown if ongoing, constipation from an unknown date and unknown if ongoing, decreased appetite from an unknown date and unknown if ongoing, heart rate increased from an unknown date and unknown if ongoing, hypertension from an unknown date and unknown if ongoing , pulmonary embolism from an unknown date and unknown if ongoing, neoplasm malignant from an unknown date and unknown if ongoing , abdominal discomfort from an unknown date and unknown if ongoing. No known allergies were reported. List of any medication's patient was using at or around the time of the adverse events and dates of therapy included Inlyta, and Famotidine. Concomitant medication included famotidine (FAMOTIDINE) taken for an unspecified indication, start and stop date were not reported. The patient previously took bnt162b2 for COVID-19 immunisation, pepcid ac for abdominal discomfort. Patient reported, stated "I have the hoarseness, I am a little constipated, I have the loss of appetite. I am fatigued. I have the rapid heartbeat. anything I do, my heart goes crazy. have high blood pressure - slightly elevated. I have a blood clot on the bottom of my lungs (doctor wants him to start on eliquis)- CT scan shows blood clot is caused by my cancer. I cannot take advil is cause of my cause of my kidney, I take pepcid for upset stomach. sometimes when I eat food my nose runs - all food. I am over my treatment, I am so freaking tired. work sent me home (because of it). I had a reaction to the COVID shot second one. 10may2021. I went to work feeling fine and the next thing feel really lousy went home and rested and was better. felt a little drained, I am tired of therapy I have had enough. I have no freaking energy. The outcome of the events was reported as unknown.  Information on the lot/batch number has been requested.
This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of VARIVAX, lot # N010108, expiration date: 20-MAR-2019, for prophylaxis (dose #, route and anatomical location of administration were unknown). The dose was stored from -14 Celsius degrees (C) to -10 C (-14.1 C) for 76 minutes, from -9 C to 8 C (-8.7 C) for 103 minutes, and from -14 C to -10 C (-11.2 C) for 11 hours. The temperature excursion was detected by a data logger. The sterile diluent (manufacturer unknown) used for reconstitution was properly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1712USA006541: US-009507513-1712USA006542: US-009507513-1712USA006543: US-009507513-1712USA006544: US-009507513-1712USA006545.
Developed fever early evening. Fatigue, headache, chills. Fever of 101.3 the next morning (4/6). Symptoms subsided within 24hrs.
lymph nodes in her neck was swollen with pain; lymph nodes was swollen under her arm with pain; redness around the injection site; swelling at the injection site; itchiness around the injection site; rash at the injection site; pain in the injection site; A spontaneous report was received from a consumer concerning a 38-years-old  female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events- pain in the injection site, lymph nodes was swollen under her arm with pain, lymph nodes in her neck was swollen with pain, redness around the injection site, swelling at the injection site, rash at the injection site, itchiness around the injection site.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 5 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown)via unknown route for prophylaxis of COVID-19 infection.  On 5 Feb 2021, the patient experienced pain, redness, swelling,rash and itchiness at the injection site . On 9 Feb 2021, the lymph nodes was swollen under her arm with pain . On 10 Feb 2021,  lymph nodes in her neck was swollen with pain.  Treatment details included none.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events- pain, redness, swelling,rash and itchiness at the injection site , the lymph nodes was swollen under her arm with pain, lymph nodes in her neck was swollen with pain- was considered to be unknown.
Narrative: Patient received both Pfizer Covid 19 Vaccines in March 2021. The patient tested positive for COVID 19 ON 4 September 2021 and was admitted to the hospital with severe hypotension, sepsis, and Covid pneumonia. The patient was treated and discharged with some improvement on 17 September 2021. The EUA requires any patient that received the vaccine and tests positive for COVID 19 with hospitalization must be reported.
swelling all over face, neck, lymphnodes, abdomen, and hands.; swelling all over face, neck, lymphnodes, abdomen, and hands.; swelling all over face, neck, lymphnodes, abdomen, and hands.; swelling all over face, neck, lymphnodes, abdomen, and hands.; swelling all over face, neck, lymphnodes, abdomen, and hands.; Water retention still in hands, neck abdomen breasts, and lymphnodes; This is a spontaneous report from a contactable consumer (patient reported for herself). A 62-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, solution for injection, Lot Number: 6955, expiry date not reported) via an unspecified route of administration, administered in left arm on 25Mar2021 (at the age of 62 years old as reported) as dose 2, single for covid-19 immunization. Medical history included known allergies to insects, bees and penicillin products. The patient was not pregnant at the time of the vaccination and report. The patient had no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not received other medications within 2 weeks of vaccination. The patient previously received Covid-19 vaccine (bnt162b2) for covid-19 immunisation on 04Mar2021 at 2:00pm at the age of 62 years old (lot number EN6204) administered in the right arm. The patient previously took amoxicillin and experienced allergy. On 27Mar2021 12:00, two days after shot, the patient had swelling all over face, neck, lymphnodes, abdomen, and hands. Doctor said to take Benadryl however patient had continued swelling and went back to doctor and was given 5 day methylprednisone. Patient was then still swelling and got steroid shot. One day fine, then back to swelling in all areas. On Saturday, patient had 3 day steroid shot.  Water retention still in hands, neck abdomen, breasts, and lymphnodes (since 27Mar2021 12:00).  Patient was taking claritin/ benydryl to help with symptoms and worst in the morning when awaken. Patient was sleeping sitting up. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events were reported as serious medically significant. Therapeutic measures were taken in response to the events which included steroid shots, and antihistamines, along with prednisone. Since the vaccination, the patient has not been tested for COVID-19.  The patient had not recovered from the events reported.
Dizziness, Arthralgia, fatigue, rash on tops of feet, brain fog and injection site pain Narrative:
Patient received FLUZONE HD on right arm and PNEUMOVAX 23 on left arm. The next day she woke up with pain on left arm. It was warm to touch and swollen and hard at injection site. There were red freckles (rash) around the injection site at down to her elbow. She put heating pad on it and took ALEVE. The next day it was one big rash on arm. Talked to her today (third day) and the rash is fading, but when press on injection site it is tender. It is getting better. She currently does not have a primary care physician. No problem with right arm where FLUZONE HD was administered.
pt recvd vax 28AUG92 & w/in 1 hr, pt felt hot & exp diaphoresis, weakness, faint & nausea; sx subsided w/in a few hrs; No further detials were provided;
lymph node on her chin swelled; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph node on her chin swelled) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced LYMPHADENOPATHY (lymph node on her chin swelled). At the time of the report, LYMPHADENOPATHY (lymph node on her chin swelled) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No medical history   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: TCR: Outcome of the event received no other follow-up
On 10/03/2018 around 4:19 AM I woke up to use the restroom, as soon as I finished using the bathroom, I had intense ringing in both ears, along with nausea, felt like throat was closing up, burning in chest and throat, head felt really hot, sweating, shortness of breath, heart racing, seeing white. I had my mom take me to the hospital. On 10/04/2018 around 12:30 AM, I felt the same symptoms coming on as the previous morning, but acutely. All of a sudden I felt very dizzy and weak. My body started to uncontrollably shake all over, and I had my mom rush me to the hospital. On 10/05/2018 I woke up around 10:30 AM and had signs of vertigo. Dizziness, ringing in ears, felt unbalanced like my equilibrium was off. I performed the BPPV test and had my mom record my eyes to see if they were moving and they were. I visited my primary care and he said these were all signs my nervous system was reacting to the shot. He diagnosed me with acute GBS.
Patient stated that pain in the areas surrounding the vaccine site started on Mon., Oct. 14; 2 days following vaccination. The pain radiates to her elbow and her shoulder. The vaccine site itself is not painful. There is no redness or swelling at the site. Advised an ER or MD visit.
Left arm pain since 11pm 9/6/11 below the deltoid - not at injection site/below deltoid down.
Dry rash on head after second vaccination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (Dry rash on head after second vaccination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Dry rash on head after second vaccination). At the time of the report, RASH (Dry rash on head after second vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment information was provided.